Telomir Pharmaceuticals OverviewTelomir Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for TELO.
Quarterly Other Income/Expense
$50389.00
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$168080.00
↓ 97.22% YoY
Trailing 12 months ending Mar 31, 2026